Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes

AAPS Journal

Volumn 11, Issue 3, 2009, Pages 469-480

  Di, Yuan Ming ^a   Chan, Eli ^b   Wei, Ming Qian ^c   Liu, Jun Ping ^d   Zhou, Shu Feng ^a  

^a RMIT UNIVERSITY   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c GRIFFITH UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Phenotype; PolyPhen; SIFT; SNP; UGT

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A10; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A5; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 1A9; GLUCURONOSYLTRANSFERASE 2A1; GLUCURONOSYLTRANSFERASE 2A2; GLUCURONOSYLTRANSFERASE 2A3; GLUCURONOSYLTRANSFERASE 2B10; GLUCURONOSYLTRANSFERASE 2B11; GLUCURONOSYLTRANSFERASE 2B15; GLUCURONOSYLTRANSFERASE 2B28; GLUCURONOSYLTRANSFERASE 2B4; GLUCURONOSYLTRANSFERASE 2B7; GLUCURONOSYLTRANSFERASE 3A1; GLUCURONOSYLTRANSFERASE 3A2; GLUCURONOSYLTRANSFERASE 8; UNCLASSIFIED DRUG;

ALGORITHM; AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; PHENOTYPE; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

AMINO ACIDS; GLUCURONOSYLTRANSFERASE; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 73349093079     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-009-9126-z     Document Type: Article

References (81)

1. C Guillemette 2003 Pharmacogenomics of human UDP-glucuronosyltransferase enzymes Pharmacogenomics J. 3 136 158 12815363 10.1038/sj.tpj.6500171 1:CAS:528:DC%2BD3sXks1Cnu7w%3D (Pubitemid 36850156)
2. WE Evans MV Relling 1999 Pharmacogenomics: translating functional genomics into rational therapeutics Science. 286 487 491 10521338 10.1126/science.286.5439.487 1:CAS:528:DyaK1MXmvVOhtL0%3D
3. PI Mackenzie IS Owens B Burchell, et al. 1997 The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence Pharmacogenetics. 7 255 269 9295054 10.1097/00008571-199708000-00001 1:CAS:528:DyaK2sXmt1WqtLo%3D (Pubitemid 27358064)
4. CD King GR Rios MD Green TR Tephly 2000 UDP-glucuronosyltransferases Curr Drug Metab. 1 143 161 11465080 10.2174/1389200003339171 1:CAS:528: DC%2BD3cXntlOrs70%3D
5. PI Mackenzie KW Bock B Burchell, et al. 2005 Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily Pharmacogenet Genomics. 15 677 685 16141793 10.1097/01.fpc.0000173483.13689.56 1:CAS:528: DC%2BD2MXpslahtLY%3D
6. D Harding SJ Jeremiah S Povey B Burchell 1990 Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1 Ann Hum Genet. 54 17 21 2108603 10.1111/j.1469-1809.1990.tb00356.x 1:STN:280:DyaK3c3htVGisw%3D%3D
7. D Turgeon JS Carrier E Levesque DW Hum A Belanger 2001 Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members Endocrinology. 142 778 787 11159850 10.1210/en.142.2.778 1:CAS:528:DC%2BD3MXhtFSrt7o%3D (Pubitemid 32222427)
8. V Ramensky P Bork S Sunyaev 2002 Human non-synonymous SNPs: server and survey Nucleic Acids Res. 30 3894 3900 12202775 10.1093/nar/gkf493 1:CAS:528:DC%2BD38Xms1Klt7k%3D
9. PC Ng S Henikoff 2002 Accounting for human polymorphisms predicted to affect protein function Genome Res. 12 436 446 11875032 10.1101/gr.212802 1:CAS:528:DC%2BD38XitFSltLg%3D (Pubitemid 34233019)
10. PC Ng S Henikoff 2006 Predicting the effects of amino acid substitutions on protein function Annu Rev Genomics Hum Genet. 7 61 80 16824020 10.1146/annurev.genom.7.080505.115630 1:CAS:528:DC%2BD28Xht1WgsrzJ (Pubitemid 44627922)
11. S Herrgard SA Cammer BT Hoffman, et al. 2003 Prediction of deleterious functional effects of amino acid mutations using a library of structure-based function descriptors Proteins. 53 806 816 14635123 10.1002/prot.10458 1:CAS:528:DC%2BD3sXhtVWgtrbJ (Pubitemid 37490434)
12. RJ Dobson PB Munroe MJ Caulfield MA Saqi 2006 Predicting deleterious nsSNPs: an analysis of sequence and structural attributes BMC Bioinformatics. 7 217 16630345 10.1186/1471-2105-7-217 (Pubitemid 44026761)
13. U Ehmer A Vogel JK Schutte B Krone MP Manns CP Strassburg 2004 Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4 Hepatology. 39 970 977 15057901 10.1002/hep.20131 1:CAS:528:DC%2BD2cXjtlCqsrg%3D (Pubitemid 38428936)
14. C Guillemette RC Millikan B Newman DE Housman 2000 Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans Cancer Res. 60 950 956 10706110 1:CAS:528:DC%2BD3cXhs1Shs7w%3D
15. JF Crigler Jr VA Najjar 1952 Congenital familial nonhemolytic jaundice with kernicterus Pediatrics. 10 169 180 12983120
16. M Black BH Billing 1969 Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and Gilbert's syndrome N Engl J Med. 280 1266 1271 5770050 1:STN:280:DyaF1M7oslCjsw%3D%3D
17. N Moghrabi DJ Clarke M Boxer B Burchell 1993 Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2 Genomics. 18 171 173 8276413 10.1006/geno.1993.1451 1:CAS:528:DyaK2cXitFCnu7k%3D (Pubitemid 23305032)
18. PJ Bosma JR Chowdhury TJ Huang, et al. 1992 Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I Faseb J. 6 2859 2863 1634050 1:CAS:528:DyaK38Xlt12itbk%3D
19. L Iyer S Das L Janisch, et al. 2002 UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity Pharmacogenomics J. 2 43 47 11990381 10.1038/sj.tpj.6500072 1:CAS:528:DC%2BD38Xitl2ju7k%3D (Pubitemid 34982202)
20. Y Ando H Saka M Ando, et al. 2000 Polymorphisms of UDP- glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis Cancer Res. 60 6921 6926 11156391 1:CAS:528:DC%2BD3MXjsVOjsA%3D%3D
21. E Wasserman A Myara F Lokiec, et al. 1997 Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports Ann Oncol. 8 1049 1051 9402181 10.1023/A:1008261821434 1:STN:280:DyaK1c%2FmtlOksQ%3D%3D (Pubitemid 27475739)
22. N Kaniwa K Kurose H Jinno, et al. 2005 Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C> T (P229L) found in an African-American Drug Metab Dispos. 33 458 465 15572581 10.1124/dmd.104.001800 1:CAS:528:DC%2BD2MXisFSgt74%3D (Pubitemid 40279948)
23. TM Danoff DA Campbell LC McCarthy, et al. 2004 A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia Pharmacogenomics J. 4 49 53 14647407 10.1038/sj.tpj.6500221 1:CAS:528: DC%2BD2cXltFantA%3D%3D (Pubitemid 38256605)
24. CP Strassburg A Vogel S Kneip RH Tukey MP Manns 2002 Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer Gut. 50 851 856 12010889 10.1136/gut.50.6.851 1:CAS:528:DC%2BD38XkvVGktL4%3D (Pubitemid 34539049)
25. Z Zheng JY Park C Guillemette SP Schantz P Lazarus 2001 Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk J Natl Cancer Inst. 93 1411 1418 11562393 10.1093/jnci/93.18.1411 1:CAS:528:DC%2BD3MXns1yrt7w%3D
26. A Vogel J Ockenga U Ehmer, et al. 2002 Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer Z Gastroenterol. 40 497 502 12122597 10.1055/s-2002-32805 1:CAS:528:DC%2BD38XmsFaqtrc%3D (Pubitemid 34856989)
27. A Vogel S Kneip A Barut, et al. 2001 Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene Gastroenterology. 121 1136 1144 11677206 10.1053/gast.2001.28655 1:CAS:528:DC%2BD3MXpt1Srsb8%3D
28. DS Darbari RH van Schaik EV Capparelli S Rana R McCarter J van den Anker 2008 UGT2B7 promoter variant -840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease Am J Hematol. 83 200 202 17724700 10.1002/ajh.21051 1:CAS:528:DC%2BD1cXjsFylu7Y%3D (Pubitemid 351303943)
29. M Holthe TN Rakvag P Klepstad, et al. 2003 Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients Pharmacogenomics J. 3 17 26 12629580 10.1038/sj.tpj.6500139 1:CAS:528:DC%2BD3sXhslyjtrk%3D (Pubitemid 36432463)
30. SL MacLeod S Nowell J Plaxco NP Lang 2000 An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer Ann Surg Oncol. 7 777 782 11129427 10.1007/s10434-000-0777-3 1:STN:280:DC%2BD3M7gsV2msg%3D%3D
31. PC Ng S Henikoff 2001 Predicting deleterious amino acid substitutions Genome Res. 11 863 874 11337480 10.1101/gr.176601 1:CAS:528:DC%2BD3MXjs1Wmu7w%3D (Pubitemid 32447869)
32. PC Ng S Henikoff 2003 SIFT: predicting amino acid changes that affect protein function Nucleic Acids Res. 31 3812 3814 12824425 10.1093/nar/gkg509 1:CAS:528:DC%2BD3sXltVWjs7s%3D (Pubitemid 37442253)
33. S Sunyaev V Ramensky I Koch W Lathe 3rd AS Kondrashov P Bork 2001 Prediction of deleterious human alleles Hum Mol Genet. 10 591 597 11230178 10.1093/hmg/10.6.591 1:CAS:528:DC%2BD3MXit1ehtbs%3D
34. PC Ng JG Henikoff S Henikoff 2000 PHAT: a transmembrane-specific substitution matrix. Predicted hydrophobic and transmembrane Bioinformatics. 16 760 766 11108698 10.1093/bioinformatics/16.9.760 1:CAS:528:DC%2BD3MXovFWi
35. A Krogh B Larsson G von Heijne EL Sonnhammer 2001 Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes J Mol Biol. 305 567 580 11152613 10.1006/jmbi.2000.4315 1:CAS:528:DC%2BD3MXisFCguw%3D%3D (Pubitemid 33032862)
36. A Lupas M Van Dyke J Stock 1991 Predicting coiled coils from protein sequences Science. 252 1162 1164 10.1126/science.252.5009.1162 1:CAS:528:DyaK3MXkvVOksLw%3D
37. H Nielsen J Engelbrecht S Brunak G von Heijne 1997 Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites Protein Eng. 10 1 6 9051728 10.1093/protein/10.1.1 1:CAS:528: DyaK2sXhsVersrs%3D
38. T Xi IM Jones HW Mohrenweiser 2004 Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function Genomics. 83 970 979 15177551 10.1016/j.ygeno.2003. 12.016 1:CAS:528:DC%2BD2cXksFKisL0%3D (Pubitemid 38726046)
39. S Aono Y Adachi E Uyama, et al. 1995 Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome Lancet. 345 958 959 7715297 10.1016/S0140-6736(95)90702-5 1:STN:280:DyaK2M3jtFWhsA%3D%3D
40. M Ciotti F Chen FF Rubaltelli IS Owens 1998 Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease Biochim Biophys Acta. 1407 40 50 9639672 1:CAS:528: DyaK1cXjvFOjsr4%3D
41. M Ciotti R Obaray MG Martin IS Owens 1997 Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis Am J Med Genet. 68 173 178 9028453 10.1002/(SICI)1096-8628(19970120) 68:2<173::AID-AJMG10>3.0.CO;2-R 1:STN:280:DyaK2s7otVaktQ%3D%3D (Pubitemid 27081834)
42. M Ciotti SL Werlin IS Owens 1999 Delayed response to phenobarbital treatment of a Crigler-Najjar type II patient with partially inactivating missense mutations in the bilirubin UDP-glucuronosyltransferase gene J Pediatr Gastroenterol Nutr. 28 210 213 9932859 10.1097/00005176-199902000-00024 1:STN:280:DyaK1M7ivFKguw%3D%3D (Pubitemid 29293691)
43. LT Erps JK Ritter JH Hersh D Blossom NC Martin IS Owens 1994 Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro J Clin Invest. 93 564 570 7906695 10.1172/JCI117008 1:CAS:528:DyaK2cXktVKmtb8%3D
44. P Labrune A Myara M Hadchouel, et al. 1994 Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases Hum Genet. 94 693 697 7989045 10.1007/BF00206965 1:CAS:528:DyaK2MXjsF2jtr4%3D
45. Y Maruo K Nishizawa H Sato H Sawa M Shimada 2000 Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate-glucuronosyltransferase gene Pediatrics. 106 E59 11061796 10.1542/peds.106.5.e59 1:STN:280:DC%2BD3M%2FlvVKguw%3D%3D
46. J Seppen PJ Bosma BG Goldhoorn, et al. 1994 Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase J Clin Invest. 94 2385 2391 7989595 10.1172/JCI117604 1:CAS:528:DyaK2MXisFWhu78%3D
47. J Seppen E Steenken D Lindhout PJ Bosma RP Elferink 1996 A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II FEBS Lett. 390 294 298 8706880 10.1016/0014-5793(96) 00677-1 1:CAS:528:DyaK28XksF2gtbY%3D (Pubitemid 26248962)
48. N Chalasani NR Chowdhury JR Chowdhury TD Boyer 1997 Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect Gastroenterology. 112 2099 2103 9178703 10.1053/gast.1997.v112.pm9178703 1:STN:280:DyaK2szit1Snuw%3D%3D (Pubitemid 27240797)
49. S Farheen S Sengupta A Santra, et al. 2006 Gilbert's syndrome: high frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene World J Gastroenterol. 12 2269 2275 16610035 1:CAS:528:DC%2BD28XltFamt7k%3D
50. CS Huang GA Luo ML Huang SC Yu SS Yang 2000 Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese Pharmacogenetics. 10 539 544 10975608 10.1097/00008571-200008000-00007 1:CAS:528:DC%2BD3cXmsFSrt7w%3D (Pubitemid 30702909)
51. A Kadakol SS Ghosh BS Sappal G Sharma JR Chowdhury NR Chowdhury 2000 Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype Hum Mutat. 16 297 306 11013440 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z 1:CAS:528:DC%2BD3cXnslCitLg%3D (Pubitemid 30740441)
52. P Labrune A Myara J Chalas B Le Bihan L Capel J Francoual 2002 Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome Hum Mutat. 20 399 401 12402338 10.1002/humu.10122 1:CAS:528:DC%2BD38XptV2nu7k%3D (Pubitemid 35285059)
53. Y Maruo E Serdaroglu M Iwai, et al. 2003 A novel missense mutation of the bilirubin UDP-glucuronosyltransferase gene in a Turkish patient with Crigler-Najjar syndrome type 1 J Pediatr Gastroenterol Nutr. 37 627 630 14581810 10.1097/00005176-200311000-00024 (Pubitemid 39280875)
54. F Petit V Gajdos L Capel, et al. 2006 Crigler-Najjar type II syndrome may result from several types and combinations of mutations in the UGT1A1 gene Clin Genet. 69 525 527 16712705 10.1111/j.1399-0004.2006.00616.x 1:STN:280:DC%2BD283otlSnsg%3D%3D (Pubitemid 43757103)
55. V Servedio M d'apolito N Maiorano, et al. 2005 Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation Hum Mutat. 25 325 15712364 10.1002/humu.9322
56. R Sutomo V Laosombat AH Sadewa, et al. 2002 Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome Pediatr Int. 44 427 432 12139570 1:CAS:528:DC%2BD38XntlSqtLc%3D
57. S Aono Y Yamada H Keino, et al. 1993 Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II Biochem Biophys Res Commun. 197 1239 1244 8280139 10.1006/bbrc.1993.2610 1:CAS:528:DyaK2cXhvVyrtL0%3D
58. CS Huang GA Luo MJ Huang ES Chen TH Young YC Chao 2001 A novel compound heterozygous variation of the uridine-diphosphoglucuronosyl transferase 1A1 gene that causes Crigler-Najjar syndrome type II Pharmacogenetics. 11 639 642 11668224 10.1097/00008571-200110000-00011 1:CAS:528:DC%2BD3MXotFWltLY%3D (Pubitemid 32953590)
59. W Udomuksorn DJ Elliot BC Lewis PI Mackenzie K Yoovathaworn JO Miners 2007 Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates Pharmacogenet Genomics. 17 1017 1029 18004206 10.1097/FPC.0b013e328256b1b6 1:CAS:528:DC%2BD2sXhsVWiu7%2FO (Pubitemid 351339486)
60. G Chen AS Blevins-Primeau RW Dellinger JE Muscat P Lazarus 2007 Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism Cancer Res. 67 9024 9029 17909004 10.1158/0008-5472.CAN-07-2245 1:CAS:528:DC%2BD2sXhtFSnur7N (Pubitemid 47535885)
61. E Levesque M Beaulieu MD Green TR Tephly A Belanger DW Hum 1997 Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene Pharmacogenetics. 7 317 325 9295060 10.1097/00008571- 199708000-00007 1:CAS:528:DyaK2sXmt1Wqtb4%3D (Pubitemid 27356932)
62. RH Tukey CP Strassburg 2000 Human UDP-glucuronosyltransferases: metabolism, expression, and disease Annu Rev Pharmacol Toxicol. 40 581 616 10836148 10.1146/annurev.pharmtox.40.1.581 1:CAS:528:DC%2BD3cXjs1yht7k%3D (Pubitemid 30340694)
63. A Gsur M Preyer G Haidinger, et al. 2002 A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk Cancer Epidemiol Biomarkers Prev. 11 497 498 12010866 1:CAS:528:DC%2BD38Xkslagt7w%3D
64. Y Li Y Wang Y Li L Yang 2006 Prediction of the deleterious nsSNPs in ABCB transporters FEBS Lett. 580 6800 6806 17141228 10.1016/j.febslet.2006.11.047 1:CAS:528:DC%2BD28XhtleisbnE (Pubitemid 44909119)
65. WE Evans JA Johnson 2001 Pharmacogenomics: the inherited basis for interindividual differences in drug response Annu Rev Genomics Hum Genet. 2 9 39 11701642 10.1146/annurev.genom.2.1.9 1:CAS:528:DC%2BD3MXos1antL0%3D (Pubitemid 35264999)
66. M Ingelman-Sundberg M Oscarson RA McLellan 1999 Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment Trends Pharmacol Sci. 20 342 349 10431214 10.1016/S0165-6147(99)01363-2 1:CAS:528:DyaK1MXns1ymsbw%3D (Pubitemid 29366813)
67. K Yamamoto Y Soeda T Kamisako, et al. 1998 Analysis of bilirubin uridine 5′-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II J Hum Genet. 43 111 114 9621515 10.1007/s100380050050 1:CAS:528:DyaK1cXjvVOntbs%3D
68. EY Zhang DJ Fu YA Pak, et al. 2004 Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586 J Pharmacol Exp Ther. 310 437 445 15075386 10.1124/jpet.104. 065912 1:CAS:528:DC%2BD2cXmtVyksrY%3D (Pubitemid 38988885)
69. Wang L. A bioinformatics approach for the phenotype prediction of non-synonymous single nucleotide polymorphisms in human cytochrome P450s. Drug Metab Dispos. 2009;37:977-91.
70. PJ Bosma B Goldhoorn RP Oude Elferink M Sinaasappel BA Oostra PL Jansen 1993 A mutation in bilirubin uridine 5′-diphosphate- glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II Gastroenterology. 105 216 220 8514037 1:STN:280:DyaK3s3pt1yitw%3D%3D
71. S Yusoff H Van Rostenberghe NM Yusoff, et al. 2006 Frequencies of A(TA)7TAA, G71R, and G493R mutations of the UGT1A1 gene in the Malaysian population Biol Neonate. 89 171 176 16210851 10.1159/000088844 1:CAS:528:DC%2BD28Xjt1Clsr8%3D
72. M Iwai Y Maruo M Ito K Yamamoto H Sato Y Takeuchi 2004 Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity J Hum Genet. 49 123 128 14986168 10.1007/s10038-003-0119-y 1:CAS:528: DC%2BD2cXisV2isbk%3D (Pubitemid 38506725)
73. B Caillier J Lepine J Tojcic, et al. 2007 A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3 Pharmacogenet Genomics. 17 481 495 17558304 10.1097/FPC.0b013e32806d87a4 1:CAS:528:DC%2BD2sXmtlShs7g%3D (Pubitemid 46905215)
74. D Wiener JL Fang N Dossett P Lazarus 2004 Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone glucuronidation phenotype in human liver microsomes Cancer Res. 64 1190 1196 14871856 10.1158/0008-5472.CAN-03-3219 1:CAS:528:DC%2BD2cXhtFCgt7w%3D (Pubitemid 38176928)
75. M Saeki Y Saito H Jinno, et al. 2005 Genetic variations and haplotypes of UGT1A4 in a Japanese population Drug Metab Pharmacokinet. 20 144 151 15855727 10.2133/dmpk.20.144
76. C Guillemette JK Ritter DJ Auyeung FK Kessler DE Housman 2000 Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene Pharmacogenetics. 10 629 644 11037804 10.1097/00008571-200010000-00006 1:CAS:528:DC%2BD3cXnsFCrtbY%3D (Pubitemid 30769712)
77. L Villeneuve H Girard LC Fortier JF Gagne C Guillemette 2003 Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs J Pharmacol Exp Ther. 307 117 128 12944498 10.1124/jpet.103.054072 1:CAS:528: DC%2BD3sXnslGktb8%3D (Pubitemid 37151897)
78. YH Huang A Galijatovic N Nguyen, et al. 2002 Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3 Pharmacogenetics. 12 287 297 12042666 10.1097/00008571-200206000-00004 1:CAS:528:DC%2BD38XnsFKru7g%3D (Pubitemid 34620656)
79. H Jinno M Saeki Y Saito, et al. 2003 Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients J Pharmacol Exp Ther. 306 688 693 12730278 10.1124/jpet.103.051250 1:CAS:528:DC%2BD3sXlslGlu78%3D (Pubitemid 36886169)
80. M Saeki S Ozawa Y Saito, et al. 2002 Three novel single nucleotide polymorphisms in UGT1A10 Drug Metab Pharmacokinet. 17 488 490 15618702 10.2133/dmpk.17.488 1:CAS:528:DC%2BD3sXhtFanu7s%3D
81. I Martineau A Tchernof A Belanger 2004 Amino acid residue ILE211 is essential for the enzymatic activity of human UDP-glucuronosyltransferase 1A10 (UGT1A10) Drug Metab Dispos. 32 455 459 15039300 10.1124/dmd.32.4.455 1:CAS:528:DC%2BD2cXis1ehurs%3D (Pubitemid 38420281)